Novavax erases doubts about its ability to remain in business
(Reuters) - COVID-19 vaccine maker Novavax, on Friday, erased doubts about its ability to remain in business by removing a so...
7h ago
France's Sanofi in COVID-19 vaccine deal with Novavax
PARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to sell a stand-alone COVID-19...
7h ago
Mettler-Toledo raises annual profit forecast despite expecting persistent weak demand
(Reuters) - Medical equipment maker Mettler-Toledo International raised its annual profit forecast on Thursday despite antici...
15h ago
Insulet misses first-quarter profit estimates as marketing costs weigh
(Reuters) - Insulet Corp reported first-quarter profit that missed market expectations on Thursday, weighed by higher marketi...
15h ago
US to post influenza A wastewater data online to assist bird flu probe, official says
By Julie Steenhuysen CHICAGO (Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) is planning to post data on...
15h ago
Masimo prepared to provide one board seat if activist Politan drops proxy contest
(Reuters) -Masimo said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a ...
20h ago
NYC sued for denying gay employees in vitro fertilization coverage
By Daniel Wiessner (Reuters) - New York City was hit with a lawsuit on Thursday claiming it discriminates against gay male ci...
23h ago
Drugmaker Abbott India posts Q4 profit rise on higher sales
BENGALURU (Reuters) - Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales...
May 09, 2024
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
(Reuters) - Drugmaker Viatris narrowly missed first-quarter revenue estimates on Thursday, hurt by weak sales for its older d...
May 09, 2024
Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies
(Reuters) - Metaphore Biotechnologies said on Thursday it would collaborate with Novo Nordisk to develop up to two therapies ...
May 09, 2024